(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 5.61% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.6%.
Sotera Health Co's revenue in 2025 is $1,106,788,000.On average, 2 Wall Street analysts forecast SHC's revenue for 2025 to be $329,362,719,464, with the lowest SHC revenue forecast at $328,780,816,562, and the highest SHC revenue forecast at $329,944,622,365. On average, 3 Wall Street analysts forecast SHC's revenue for 2026 to be $348,725,325,626, with the lowest SHC revenue forecast at $343,106,982,147, and the highest SHC revenue forecast at $351,988,807,412.
In 2027, SHC is forecast to generate $373,983,317,821 in revenue, with the lowest revenue forecast at $373,663,980,863 and the highest revenue forecast at $374,302,654,779.